Heartsciences Inc. Announces Conversion of Preferred Shares and Debt Exchange, Issuing Over 2.6 Million Shares of Common Stock
HeartSciences Inc. has announced a significant financial update involving the conversion of preferred shares and a debt exchange. As of September 5, 2025, the company reported the receipt of $5.4 million in gross proceeds from its Regulation A Offering, leading to the issuance of 1,556,409 units. Notably, holders of 1,054,549 shares of Series D Preferred Stock have opted to convert their shares into common stock. Additionally, HeartSciences has successfully exchanged $1,805,000 of an unsecured promissory note for 506,348 shares of common stock, effectively reducing the principal amount of the note. Consequently, the total number of common stock shares issued and outstanding now stands at 2,654,540. These strategic financial maneuvers aim to strengthen the company's capital structure and enhance its financial flexibility.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468492-25-000006), on September 08, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。